ORMP icon

Oramed Pharmaceuticals
ORMP

Overview Fund Activity

25 hedge funds and large institutions have $3.83M invested in Oramed Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 6 closing their positions.

Holders
25
Holders Change
-3
Holders Change %
-10.71%
% of All Funds
0.54%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
3
Increased
5
Reduced
3
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$382K
2
Deutsche Bank
2
Deutsche Bank
Germany
$38K
3
DCM
3
DAFNA Capital Management
California
$95K
4
CAM
4
Close Asset Management
United Kingdom
$27K
5
PAM
5
Panagora Asset Management
Massachusetts
$47K

Top Sellers

1
AC
1
Armistice Capital
New York
$0
2
SM
2
Sabby Management
Florida
$2.48M
3
SFFS
3
Stonehage Fleming Financial Services
Jersey
$0
4
Northern Trust
4
Northern Trust
Illinois
$0
5
Group One Trading
5
Group One Trading
Illinois
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
AC
26
Armistice Capital
New York
– -$1.63M -542,944 Closed
SFFS
27
Stonehage Fleming Financial Services
Jersey
– -$231K -76,909 Closed
Northern Trust
28
Northern Trust
Illinois
– -$55K -18,269 Closed
Group One Trading
29
Group One Trading
Illinois
– -$51K -16,900 Closed
Simplex Trading
30
Simplex Trading
Illinois
– -$3K -1,035 Closed
FHA
31
Flagship Harbor Advisors
Massachusetts
– -$2K -700 Closed
1
2